|

Validating CGM for GDM

RECRUITINGN/ASponsored by Icahn School of Medicine at Mount Sinai
Actively Recruiting
PhaseN/A
SponsorIcahn School of Medicine at Mount Sinai
Started2025-10-02
Est. completion2028-04
Eligibility
Age18 Years – 50 Years
SexFEMALE
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT06858787

Summary

This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.

Eligibility

Age: 18 Years – 50 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Ages 18-50
* Singleton pregnancy between 24-32 weeks gestational age
* Prenatal care and delivery at Mount Sinai Hospital

Exclusion Criteria:

* Multiple fetal gestation
* Preexisting diabetes
* Concurrent use of steroids
* Anomalous fetus
* Insufficient prenatal care (identified as missing half the recommended visits or establishing care after 20 weeks gestation)
* Unable to tolerate oral glucose test

Conditions2

DiabetesGestational Diabetes Mellitus (GDM)

Locations2 sites

Icahn School of Medicine at Mount Sinai
New York, New York, 10029
Nicola Tavella, MPH2122413888nicola.tavella@mssm.edu
Mount Sinai South Nassau
Oceanside, New York, 11572
Dina El Kady, MD

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.